Northern Venture Trust PLC
29 December 2004
NORTHERN VENTURE TRUST PLC ('The Company')
DIRECTOR SHAREHOLDING
Further to the Issue of Equity announcement released earlier today, of the
435,079 ordinary shares allotted today under the terms of the Company's Dividend
Investment Scheme, 1,457 ordinary shares were allotted to Professor Sir
Frederick Holliday, a director of the Company at a price of 89.6p per share. As
a result of this allotment, Professor Holliday currently has a beneficial
interest in 14,517 ordinary shares of 25p each in the Company representing 0.04%
per cent of the enlarged issued share capital.
END
This information is provided by RNS
The company news service from the London Stock Exchange
DSUKURRSKRUUAA
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.